español

Suanfarma sells Halotech to ST Technologies

Suanfarma has exited biotechnology company Halotech DNA via a trade sale to Sexing Technologies, a business that specializes in the gender identification of beef-cattle semen.

Halotech has developed and commercialized in vitro diagnostic kits to assess DNA fragmentation in human and animal sperm cells.

Based in the Madrid Science Park, it was created by Suan Biotech on collaboration with Autonomous University of Madrid spin-off Chromacell.

Susannah Birkwood, 3 november 2010. Southern Europe unquote.

© 2013 Fina Biotech. Madrid. Tel +34 917 991 564 info@finabiotech.es

Enlaces a redes sociales